NCT03034889

Brief Summary

The infantile brain has to pass essential, mayor steps in the first 36 months of life. During that period of development it is particularly vulnerable to toxic, exogenic influences. This study wants to review the long-term effects of children who were exposed to anesthesia in the first three years of their life. Therefore the investigators will examine children at age of 4-10 that were exposed to anesthesia and compare their neurocognitive capacity to children who did not have any exposure to anesthesia. The investigators plan on measuring the intelligence quotient using standardized tests which will be performed by a trained psychologist. In addition there will be a questionnaire concerning behavioral characteristics and educational development which is filled by the parents. The exposed children will be recruited from our preexisting database, the control group will be recruited from practitioners and the pediatric walk-in-clinic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

January 23, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 27, 2017

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

March 24, 2020

Status Verified

March 1, 2020

Enrollment Period

2.9 years

First QC Date

January 23, 2017

Last Update Submit

March 23, 2020

Conditions

Keywords

AnesthesiaChildrenGeneral AnesthesiaNeurocognitive Outcome

Outcome Measures

Primary Outcomes (3)

  • Cognitive Capacity for children between 7 and 10 years of age

    Standardized tests for intelligence quotient (IQ): Kaufman Assessment Battery for Children - Second Edition (KABC-II)

    Test is done 1 to 10 years after anesthesia and is lasting 3 hours

  • Cognitive Capacity for children between 4 and 7 years of age

    Standardized tests for intelligence quotient (IQ): Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III)

    Test is done 1 to 10 years after anesthesia and is lasting 3 hours

  • Cognitive Capacity for children between 2 and 4 years of age

    Standardized tests for intelligence quotient (IQ): Wechsler Intelligence Scale for Children (WISC-IV)

    Test is done 1 to 10 years after anesthesia and is lasting 3 hours

Secondary Outcomes (1)

  • Educational status

    1 to 10 years after anesthesia, lasting 30 minutes

Study Arms (2)

Exposed

Children age 4-10 who required general anesthesia before the age of 36 months in the context of surgical and diagnostic procedures or sedation during intensive care, excluding neurosurgical interventions or cardiac surgery as well as preexisting hereditary or acquired neurocognitive deficits

Control

Children age 4-10 who did not require any anesthesia before the age of 36 months. Excluding preexisting hereditary or acquired neurocognitive deficits.

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children age 4-10 who underwent general anesthesia below the age of 36 months in context of surgical or diagnostic procedures or sedation uring intensive care.

You may qualify if:

  • General anesthesia before the age of 36 months

You may not qualify if:

  • neurosurgical interventions
  • cardiac surgery
  • preexisting hereditary or acquired cognitive deficits
  • no informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Erlangen, Bavaria, 91054, Germany

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

January 23, 2017

First Posted

January 27, 2017

Study Start

January 1, 2017

Primary Completion

December 1, 2019

Study Completion

March 1, 2020

Last Updated

March 24, 2020

Record last verified: 2020-03

Locations